Brief: Celadon Pharmaceuticals HY Loss Before Tax Of £4.4 Million

Celadon Pharmaceuticals

28/09/2023 08:25

Sept 28 (Reuters) - Celadon Pharmaceuticals PLC  CEL.L :
    * CELADON PHARMACEUTICALS PLC H1 REVENUE 8000 STG VERSUS
11,000
STG YEAR AGO
    * CELADON PHARMACEUTICALS - INAUGURAL £3M PRODUCT SALE OVER
3
YEARS TO  LEADING UK MEDICAL CANNABIS COMPANY - FIRST SHIPMENTS
ANTICIPATED IN Q4 2023
    * CELADON PHARMACEUTICALS PLC - HY LOSS BEFORE TAX OF £4.4
MILLION
(30 JUNE 2022: £13.5 MILLION)

Source text for Eikon:  ID:nRSb9058Na 
Further company coverage:  CEL.L 

 ((Reuters.Briefs@thomsonreuters.com;))